{"SPADE_UN_13847": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13847", "Peptide Name": "SARS-CoV (864-886)", "Source": "Synthetic construct", "Family": "Coronaviridae", "Gene": "Not found", "Sequence": "ATAGWTFGAGAALQIPFAMQMAY", "Sequence Length": 23, "UniProt Entry": ["http://www.uniprot.org/uniprot/Q19QX0"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Antiviral"], "Target Organism": "[Ref.16616792]SARS-CoV:inhibition of  virus infection in Vero-E6 cells(39% inhibition at 30 μM).", "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry", "Cytotoxicity": "[Ref.16616792]No cytotoxic at a concentration of 30 μM on Vero-E6 cells", "Binding Target": "cell membrane", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C110H160N26O29S2", "Mass": 2374.73, "PI": 5.57, "Net Charge": 0, "Hydrophobicity": 0.73, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Mechanism of action": "inhibits viral entry through coiled coil interactions.", "Literature": [{"Title": "Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein.", "Pubmed ID": "16616792", "Reference": "Virus Res. 2006 Sep;120(1-2)146-55.", "Author": "Sainz B Jr, Mossel EC, Gallaher WR, Wimley WC, Peters CJ, Wilson RB, Garry RF.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16616792"}], "Frequent Amino Acids": "AGF", "Absent Amino Acids": "CDEHKNORSUV", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 16, "Polar Residues": 12, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": []}}}